HCXY Market Analysis

Overview

Fundamentals

P/E ratio19.25
EPS (TTM)0.0% YoY
Profit margin0.0%FINANCIALS
Market cap$1.31BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
5.0%
Beta
Last earnings
Oct 30, 2025 · Estimate $0.00 · Reported $0.63
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Hercules Capital Inc

Hercules Capital Inc (HCXY) is a prominent publicly traded business development company focused on providing tailored financing solutions to growth-stage enterprises, predominantly in the life sciences and technology sectors. By utilizing its extensive industry expertise and strategic partnerships, Hercules delivers customized debt and equity financing that fosters innovation and value creation. With a strong emphasis on capital preservation and generating risk-adjusted returns, the company presents an attractive opportunity for institutional investors seeking diversified exposure to…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$1.31B
Shares outstanding$0
52W high$25.21
52W low$22.95

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer